Indian J Pharm Close
 

Figure 4: The 3-year overall survival rate of cetuximab plus chemoradiotherapy versus chemoradiotherapy (random-effect model)

Figure 4: The 3-year overall survival rate of cetuximab plus chemoradiotherapy versus chemoradiotherapy (random-effect model)